Molly White
Corporate Officer/Principal bij DYNE THERAPEUTICS, INC.
Profiel
Molly White is currently the Vice President-Strategic Initiatives at Dyne Therapeutics, Inc. She previously served as the Chief Executive Officer at Myotonic Dystrophy Foundation from 2012 to 2019.
Ms. White holds a graduate degree from the University of Iowa and an undergraduate degree from The University of Montana.
Actieve functies van Molly White
| Bedrijven | Functie | Begin |
|---|---|---|
| DYNE THERAPEUTICS, INC. | Corporate Officer/Principal | 01-01-2020 |
Eerdere bekende functies van Molly White
| Bedrijven | Functie | Einde |
|---|---|---|
Myotonic Dystrophy Foundation
 Myotonic Dystrophy Foundation Investment Trusts/Mutual FundsMiscellaneous The Myotonic Dystrophy Foundation is a non-profit organization that supports families living with myotonic dystrophy by providing comprehensive resources and driving research to accelerate the discovery of therapies. The non-profit company is based in San Francisco, CA. The foundation has invested over $10,000,000 and has served more than 10,000 people. The company's mission is to support and connect the myotonic dystrophy community, provide resources and advocate for care, and accelerate research toward treatments and a cure. | Operationeel Directeur | 01-12-2019 |
Opleiding van Molly White
| University of Iowa | Graduate Degree |
| The University of Montana | Undergraduate Degree |
Ervaring
Beklede functies
Actief
Inactief
Beursgenoteerde bedrijven
Bedrijven in privébezit
Connecties
Eerstegraads connecties
Bedrijven verbonden in de eerste graad
Man
Vrouw
Besturend
Uitvoerend
Verwante bedrijven
| Beursgenoteerde bedrijven | 1 |
|---|---|
| DYNE THERAPEUTICS, INC. | Health Technology |
| Bedrijven in privébezit | 1 |
|---|---|
Myotonic Dystrophy Foundation
Myotonic Dystrophy Foundation Investment Trusts/Mutual FundsMiscellaneous The Myotonic Dystrophy Foundation is a non-profit organization that supports families living with myotonic dystrophy by providing comprehensive resources and driving research to accelerate the discovery of therapies. The non-profit company is based in San Francisco, CA. The foundation has invested over $10,000,000 and has served more than 10,000 people. The company's mission is to support and connect the myotonic dystrophy community, provide resources and advocate for care, and accelerate research toward treatments and a cure. | Miscellaneous |
